6782 — Visco Vision Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for Visco Vision, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	238	116	404	713	296
Depreciation
Amortisation
Non-Cash Items	7.68	84.7	-12.3	33.5	30.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-75.8	-97.5	-26.1	-97.2	-378
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	349	281	608	985	353
Capital Expenditures	-327	-294	-903	-932	-450
Purchase of Fixed Assets
Other Investing Cash Flow Items	-16	-293	154	-31.1	-489
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-343	-587	-748	-963	-939
Financing Cash Flow Items	209	626	710	1,020	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	40.1	354	288	1,409	-667
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	44.9	34.8	114	1,450	-1,281